Precision medicine has shown promising results in improving the diagnosis and survival rates of children with high-risk cancers. Researchers from Australia have enrolled over 1,600 children in the Zero Childhood Cancer National Precision Medicine Program and expanded the trial to include all children diagnosed with cancer in Australia. By utilizing whole genome sequencing and molecular profiling, the program has identified new cancer drivers, genetic risk factors, and targeted treatments. This approach not only benefits the patient but also has implications for genetic counseling and surveillance for relatives. The researchers aim to continue developing precision medicine to become the standard of care in the future.
Source link
Molecular profiling found to improve diagnosis and survival for children with high risk cancers
